MycoBiomDB – Record Details (MyCo_5477)

Biomarker Record Details

Database ID: MyCo_5477
DB IDMyCo_5477
TitleCombining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia
Year2015
PMID26126706
Fungal Diseases involvedInvasive pulmonary aspergillosis
Associated Medical ConditionHematological malignancies and prolonged neutropenia
GenusAspergillus
Speciesfumigatus
OrganismAspergillus fumigatus
Ethical StatementThe study protocol was approved by the ethics committee of the University Hospitals of Debrecen, Hungary.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameFacC
Biomarker Full NameFacC
Biomarker TypeDiagnostic
BiomoleculeGene
Geographical LocationHungary
CohortBetween June 06, 2012 and May 08, 2013, 27 febrile neu-tropenia episodes (FNEs); 16 males with the median age of 42.5 (range 14–75) and 11 females with the median age of 45.5 (range; 19–66)
Cohort No.27
Age Group14-75
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismPatients suffering from hematological malignancies and prolonged neutropenia are significantly affected by life- threatening invasive fungal infections, particularly invasive pulmonary aspergillosis (IPA). Despite improvements in transplantation practices and antifungal therapy the treatment of patients with IPA is still challenging. Diagnosis of IPA is difficult and delayed diagnosis contributes to the increasing severity of IPA associated high morbidity and mortality rates.
TechniquePCR
Analysis MethodFacC-PCR
ELISA kitsPlateliaTM Aspergillus EIA assay (Bio-Rad, Munich, Germany)
Assay DataNone
Validation Techniques usedGM-Platelia™ Aspergillus Ag ELISA, FacC-PCR
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone